Carl Miller
Foot & Ankle Surgery · Tulsa, OKNPI 1194991828
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,845 of the $4,444 with a category attached, or 86.5%. 22 manufacturers reported payments, led by Stryker at 48.9% of the total. Reporting peaked in 2019 at $2,060 and has fallen 88.9% since, to $229 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in OK, where the typical reported total is $3,615.
Across 129 payments — averaging $34.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Smith+Nephew$534
- Organogenesis Inc.$350
- Johnson & Johnson$222
- Zyla Life Sciences, Inc.$162
- Merck$156
- plus $848 from 16 others
What the payments were for
- Travel & lodging$59913%
- Food & beverage$3,84587%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 27 | $2,173 |
| Smith+Nephew | 37 | $534 |
| Organogenesis Inc. | 10 | $350 |
| Johnson & Johnson | 6 | $222 |
| Zyla Life Sciences, Inc. | 19 | $162 |
| Merck | 6 | $156 |
| Hydrocision, Inc. | 1 | $127 |
| Zimmer Biomet | 1 | $110 |
| Tenex Health Inc. | 1 | $107 |
| Integra Lifesciences Corporation | 1 | $101 |
| Medtronic | 3 | $86 |
| Paratek Pharmaceuticals, Inc. | 4 | $69 |
| GRT US Holding, Inc. | 3 | $46 |
| Bioventus LLC | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Mimedx Group, Inc. | 1 | $25 |
| Nevro Corp. | 1 | $23 |
| Polynovo North America LLC | 1 | $18 |
| Vertex | 1 | $17 |
| Averitas Pharma Inc. | 1 | $14 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,444 in reported general payments places this provider in the 50th percentile of 71 foot & ankle surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 59 | $2,916 |
| Clindamycin Hcl | 24 | $307 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 34 | $115 |
| Methylprednisolone | 17 | $99 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Tulsa
- Wesley StotlerTulsa$268K
- Andronica HandieTulsa$149K
- Brandon KitchensTulsa$19K
- James DaviesTulsa$15K
- Jason LiangTulsa$12K
- Nathan LashleyTulsa$6K
- Abdurrahman KabaniTulsa$4K
- David StollerTulsa$3K
- Lateef LawalTulsa$1K
- Jill Jackson-SmithTulsa$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.